SITC Archive Library

Global Access to Immunotherapy: Closing the Gaps - Day 1 

12-08-2020 18:33

The Society for Immunotherapy of Cancer (SITC) hosted the 2020 SITC Global Access to Immunotherapy: Closing the Gaps workshop on December 9-10, 2020. The purpose of this convening was to bring together immunotherapy experts from high-income countries (HIC) with experts on cancer delivery and research from low- and middle-income countries (LMIC) to define optimal approaches for overcoming health economic barriers. Other key issues that were addressed to facilitate access include: defining the minimal hospital, staff and pharmacy requirements for safe administration and monitoring of therapy; understanding how specific co-morbidities, environmental factors and local cancer epidemiology influence the safety and efficacy profile of cancer immunotherapy; understanding the regulatory and EC/IRB requirements to study and ultimately register novel immunotherapies in LMIC; and determining the most impactful approaches to provider and community education. Available here are the presentation slides and video from Day 1 (Wednesday, December 9, 2020).

Program Organizers

David Kaufman MD, PhD – Third Rock Ventures
Samir Khleif, MD – Georgetown University 

Click here to view the full Global Access to Immunotherapy: Closing the Gaps schedule along with presenter's permission to post materials.

#CoverageandReimbursement
#HospitalOperations
#PresentationSlides
#Collaboration
#CollaborativeEvent
#GovernmentInstitution
#Policy
#2021

Statistics
0 Favorited
61 Views
12 Files
0 Shares
39 Downloads
Attachment(s)
pdf file
Challenges in checkpoint blockade clinical trial design ...   260 KB   1 version
Uploaded - 12-09-2020
Presented by Anna Baran, MD, KCR Consulting (Poland) and Yaroslav Shparyk, MD, PhD, Professor of Medical Oncology – Lviv Cancer Center, Lviv, Ukraine
pdf file
Challenges in checkpoint blockade clinical trial design ...   3.20 MB   1 version
Uploaded - 12-09-2020
Presented by Anna Baran, MD, KCR Consulting (Poland) and Yaroslav Shparyk, MD, PhD, Professor of Medical Oncology – Lviv Cancer Center, Lviv, Ukraine
pdf file
the promise, potential, and Implications of cancer immun...   65 KB   1 version
Uploaded - 12-09-2020
Presented by Jennifer Dent, MBA, President & CEO – BIO Ventures for Global Health (BVGH)
pdf file
the promise, potential, and Implications of cancer immun...   3.16 MB   1 version
Uploaded - 12-09-2020
Presented by Jennifer Dent, MBA, President & CEO – BIO Ventures for Global Health (BVGH)
pdf file
Capacity considerations for innovative cancer medicines ...   328 KB   1 version
Uploaded - 12-09-2020
Presented by Marko Spasic, MD – Parker Institute for Cancer Immunotherapy
pdf file
Capacity considerations for innovative cancer medicines ...   883 KB   1 version
Uploaded - 12-09-2020
Presented by Marko Spasic, MD – Parker Institute for Cancer Immunotherapy
pdf file
Barriers and opportunities to cancer immunotherapy in Af...   158 KB   1 version
Uploaded - 12-09-2020
Presented by Nestory Masalu, MD – Bugando Medical Center
pdf file
Barriers and opportunities to cancer immunotherapy in Af...   283 KB   1 version
Uploaded - 12-09-2020
Presented by Nestory Masalu, MD – Bugando Medical Center
pdf file
mission impossible?   170 KB   1 version
Uploaded - 12-09-2020
Presented by Nora Sobrevilla-Moreno, MD – Instituto Nacional de Cancerología, Mexico City, Mexico
pdf file
mission impossible?   1.72 MB   1 version
Uploaded - 12-09-2020
Presented by Nora Sobrevilla-Moreno, MD – Instituto Nacional de Cancerología, Mexico City, Mexico
pdf file
a phase I study of rituximab hyaluronidase at the Uganda...   434 KB   1 version
Uploaded - 12-09-2020
Presented by Thomas S Uldrick, MD, MS, Deputy Head, Global Oncology – Fred Hutchinson Cancer Research Center
pdf file
a phase I study of rituximab hyaluronidase at the Uganda...   1.21 MB   1 version
Uploaded - 12-09-2020
Presented by Thomas S Uldrick, MD, MS, Deputy Head, Global Oncology – Fred Hutchinson Cancer Research Center

Related Entries and Links

No Related Resource entered.